Botulinum toxin and the treatment of primary disorders of mood and affect
US8926991B2 · kind B2 · utility
13Cited by
0References
19Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 7, 2006 |
| Grant date | Jan 6, 2015 |
| Priority date | — |
| Expiry date | Oct 23, 2028 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides methods for treating primary disorders of mood and affect, including depressive disorders, anxiety and sleep disorders and CNS disorders comprising the administration of a neurotoxin.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.